|
|
Volumn 504, Issue 7480, 2013, Pages
|
|
Adoptive cell therapy: Honing that killer instinct
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD19 ANTIGEN;
INTERLEUKIN 2;
LYMPHOCYTE ANTIGEN RECEPTOR;
MEMBRANE ANTIGEN;
T LYMPHOCYTE RECEPTOR;
TRASTUZUMAB;
TUMOR ANTIGEN;
CHIMERIC ANTIGEN RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
MELANOMA ANTIGEN 3;
UNCLASSIFIED DRUG;
ADOPTIVE CELL TRANSFER;
CANCER REGRESSION;
CELL PROLIFERATION;
CELL TRANSFER;
CHRONIC LYMPHATIC LEUKEMIA;
COLORECTAL CANCER;
CYTOKINE STORM;
DNA MODIFICATION;
DRUG INDUSTRY;
GLIOBLASTOMA;
HUMAN;
IMMUNE RESPONSE;
IMMUNOCOMPETENT CELL;
KILLER CELL;
LYMPHATIC LEUKEMIA;
MESOTHELIOMA;
METASTATIC MELANOMA;
NOTE;
OVARY CANCER;
PANCREAS CANCER;
PRIORITY JOURNAL;
SYNOVIAL SARCOMA;
T LYMPHOCYTE ACTIVATION;
TRANSLATIONAL RESEARCH;
TUMOR ASSOCIATED LEUKOCYTE;
TUMOR LYSIS SYNDROME;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADOPTIVE TRANSFER;
ANTIGEN ANTIBODY COMPLEX;
ANTIGEN SPECIFICITY;
ARTICLE;
B LYMPHOCYTE;
CANCER CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CHIMERIC ANTIGEN RECEPTOR THERAPY;
CLINICAL TRIAL (TOPIC);
MELANOMA;
NONHUMAN;
PHASE 1 CLINICAL TRIAL (TOPIC);
T LYMPHOCYTE;
ADOPTIVE TRANSFER;
CELL SEPARATION;
CLINICAL TRIALS AS TOPIC;
HISTOCOMPATIBILITY ANTIGENS;
HUMANS;
IMMUNOTHERAPY;
LYMPHOCYTES, TUMOR-INFILTRATING;
MELANOMA;
NEOPLASMS;
RECEPTORS, ANTIGEN, T-CELL;
T-LYMPHOCYTES;
ANTIGEN;
APOPTOSIS;
CANCER;
GENETIC ANALYSIS;
IMMUNE RESPONSE;
|
|
EID: 84890452839
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/504S13a Document Type: Note |
|
Times cited : (42)
|
|
References (5)
|
